Mirati Therapeutics Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Mirati Therapeutics, Inc. is now part of Bristol Myers Squibb. Follow our progress delivering breakthrough therapies that target the genetic drivers of cancer @Bristol Myers Squibb or www.bms.com